CRVS
Price
$3.63
Change
-$0.26 (-6.68%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
299.98M
90 days until earnings call
KYMR
Price
$29.75
Change
-$1.39 (-4.46%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
2.03B
79 days until earnings call
Ad is loading...

CRVS vs KYMR

Header iconCRVS vs KYMR Comparison
Open Charts CRVS vs KYMRBanner chart's image
Corvus Pharmaceuticals
Price$3.63
Change-$0.26 (-6.68%)
Volume$6.93K
Capitalization299.98M
Kymera Therapeutics
Price$29.75
Change-$1.39 (-4.46%)
Volume$54.75K
Capitalization2.03B
CRVS vs KYMR Comparison Chart
Loading...
CRVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRVS vs. KYMR commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVS is a Hold and KYMR is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (CRVS: $3.89 vs. KYMR: $31.14)
Brand notoriety: CRVS and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVS: 77% vs. KYMR: 59%
Market capitalization -- CRVS: $299.98M vs. KYMR: $2.03B
CRVS [@Biotechnology] is valued at $299.98M. KYMR’s [@Biotechnology] market capitalization is $2.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVS’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • CRVS’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRVS and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVS’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • CRVS’s TA Score: 5 bullish, 4 bearish.
  • KYMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRVS is a better buy in the short-term than KYMR.

Price Growth

CRVS (@Biotechnology) experienced а +16.12% price change this week, while KYMR (@Biotechnology) price change was +9.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.95%. For the same industry, the average monthly price growth was +6.81%, and the average quarterly price growth was -5.99%.

Reported Earning Dates

CRVS is expected to report earnings on Aug 12, 2025.

KYMR is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Biotechnology (+0.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.03B) has a higher market cap than CRVS($300M). KYMR YTD gains are higher at: -22.595 vs. CRVS (-27.290). CRVS has higher annual earnings (EBITDA): -25M vs. KYMR (-216.24M). KYMR has more cash in the bank: 489M vs. CRVS (41.7M). CRVS has less debt than KYMR: CRVS (354K) vs KYMR (87.8M). KYMR has higher revenues than CRVS: KYMR (47.1M) vs CRVS (0).
CRVSKYMRCRVS / KYMR
Capitalization300M2.03B15%
EBITDA-25M-216.24M12%
Gain YTD-27.290-22.595121%
P/E RatioN/AN/A-
Revenue047.1M-
Total Cash41.7M489M9%
Total Debt354K87.8M0%
FUNDAMENTALS RATINGS
CRVS: Fundamental Ratings
CRVS
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRVSKYMR
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
CRVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

CRVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been loosely correlated with SYRE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVS jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
-4.07%
SYRE - CRVS
37%
Loosely correlated
-1.21%
DNLI - CRVS
33%
Loosely correlated
-3.65%
VKTX - CRVS
33%
Poorly correlated
-2.00%
CCCC - CRVS
33%
Poorly correlated
-5.06%
KYMR - CRVS
32%
Poorly correlated
-3.20%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-3.20%
CCCC - KYMR
64%
Loosely correlated
-5.06%
RCKT - KYMR
57%
Loosely correlated
-5.50%
IMNM - KYMR
57%
Loosely correlated
-0.38%
RVMD - KYMR
57%
Loosely correlated
-4.61%
NRIX - KYMR
56%
Loosely correlated
-4.42%
More